Torrance, CANCT05708859Now EnrollingIRB Ready

Type II Diabetes Clinical Trial in Torrance, CA

Access cutting-edge type ii diabetes treatment through this clinical trial at a research site in Torrance. Study-provided care at no cost to qualified participants.

Sponsored by Matthew J. Budoff

Quick Self-Assessment

See if you qualify for this Torrance location

Preparing your pre-screening questions…

Expert Care in Torrance

Access type ii diabetes specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related type ii diabetes treatment provided free

Apply for This Torrance Location

Check if you qualify for this type ii diabetes clinical trial in Torrance, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Torrance

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Torrance site if eligible
  4. 4Begin participation

About This Type II Diabetes Study in Torrance

A multi-center, randomized, double-blind, placebo-controlled, parallel-group phase IV Study evaluating the effects of tirzepatide on atherosclerotic plaque progression assessed by coronary computed tomography angiography (CCTA) in participants with a diagnosis of type II Diabetes (T2DM) and atherosclerosis.

Sponsor: Matthew J. Budoff

Who Can Participate

Inclusion Criteria

Male or female 40 years to 80 years of age at signing of informed consent
Type 2 DM of minimum 5 years duration with HbA1c ≥7.0% to ≤10.5%
Body mass index (BMI) ≥25 kilograms per meter squared (kg/m²)
Presence of two discrete coronary artery plaques with visual diameter stenosis \>20% on CCTA
At the baseline visit, participants must be on a stable (\>4 weeks) regiment of diabetes medications.
Patients using oral hormonal contraceptives must switch to a non-oral contraceptive method, or add a barrier method of contraception for 4 weeks after initiation and for 4 weeks after each dose escalation

Exclusion Criteria

Have had a major cardiovascular event within the last 60 days
Have type 1 diabetes mellitus
Current use of GLP1-RA
Have a history of severe hypoglycemia and/or hypoglycemia unawareness within the last 6 months
Are currently planning treatment for diabetic retinopathy and/or macular edema
Have history of, or currently planning a coronary, carotid, or peripheral artery revascularization (ie - stent, bypass)
Have a history of pancreatitis
Have a history of ketoacidosis or hyperosmolar state/coma
Have a known clinically significant gastric emptying abnormality, have undergone or currently planning any gastric outlet obstruction, or have undergone or currently planning any gastric bypass (bariatric) surgery or restrictive bariatric surgery
Have a history of an active or untreated malignancy or are in remission from a clinically significant malignancy for less than 5 years
Have a family or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN-2)
Have had a blood transfusion or severe blood loss within 90 days prior to screening or have known hematological conditions that may interfere with HbA1c measurement
Planned or Prior Bypass surgery
Contradiction for CCTA (e.g. serious allergic reaction to the contrast dye) or CCTA not meeting entry standards after two attempts during the Baseline CCTA visit as assessed by the imaging core lab.
Uncontrolled severe hypertension: systolic blood pressure \> 180 mmHg or diastolic BP \> 100 mm Hg prior to randomization (assessed at the screening visit) despite antihypertensive therapy
Heart Failure NYHA Class III or IV at the screening visit
Renal insufficiency (eGFR \<40 ml/min/1.73m2) as measured by the Modification of Diet in Renal Disease (MDRD) formula at the screening visit.
Hospitalization for major cardiovascular event including heart failure in the past 2 months

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Torrance?

Yes, this clinical trial (NCT05708859) has an active research site in Torrance, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type II Diabetes Treatment Options in Torrance, CA

If you're searching for type ii diabetes treatment options in Torrance, CA, this clinical trial (NCT05708859) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Torrance research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type ii diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type ii diabetes clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Torrance, CA

See all pulmonary embolism clinical trials recruiting in Torrance — not just this study.

Browse Pulmonary Embolism Trials in Torrance →

Browse More Trials by Condition

Pulmonary Embolism TrialsEssential Tremor TrialsType 2 Diabetes TrialsAll Conditions →

Ready to Join in Torrance?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Torrance, CA